Parsley Health Stock

Parsley Health is redesigning primary care by integrating the latest in medical testing, technology and nutrition research.

About Parsley Health Stock

Parsley Health is a new kind of healthcare service that integrates technology, nutrition, wellness and prevention into cutting-edge primary care. The company was founded in 2016 by Dr. Robin Berzin, M.D., a Columbia-trained physician, digital health expert and leader in functional medicine. Parsley clinics are currently open in Los Angeles, New York City and San Francisco. Learn more at www.parsleyhealth.com

Funding History

June 2016	$0
June 2017	$0
April 2018	$10.0M

Management

Founder & CEO

Robin Berzin

Press

New Fund for New York Startups Won’t Take VC Money

Wall Streets Journal - Aug, 2 2018

Other Companies

Learn More

Compass Pathways

Compass Pathways will be testing the active ingredient of magic mushrooms, psylocybin, as a treatment for depression.

Spark Therapeutics is focused on the development of gene therapy.

Synaptive is a medical device and technology company pursuing connections to transform the process of care in and beyond the operating room.

Vertias Genetics' purpose is to make actionable genetic information accessible to all.

6Age (years)

$542MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Parsley Health or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 80K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2020 EquityZen Inc. All rights reserved.